USP34 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.012800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.295400E-01
Normal-vs-Stage2
2.005800E-01
Normal-vs-Stage3
3.726000E-02
Normal-vs-Stage4
2.311200E-01
Stage1-vs-Stage2
7.135800E-01
Stage1-vs-Stage3
5.794100E-02
Stage1-vs-Stage4
9.612600E-01
Stage2-vs-Stage3
1.076180E-01
Stage2-vs-Stage4
7.357400E-01
Stage3-vs-Stage4
6.860100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.045000E-01
Normal-vs-AfricanAmerican
7.987900E-02
Normal-vs-Asian
8.441000E-03
Caucasian-vs-AfricanAmerican
6.999400E-01
Caucasian-vs-Asian
2.396000E-01
AfricanAmerican-vs-Asian
3.170600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.757200E-04
Normal-vs-Female
2.113600E-01
Male-vs-Female
4.201200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.155010E-01
Normal-vs-Age(41-60Yrs)
2.512000E-01
Normal-vs-Age(61-80Yrs)
5.047900E-04
Normal-vs-Age(81-100Yrs)
1.804380E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.904600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.105800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.858400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.576700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.103500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.446000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.375790E-03
Normal-vs-Daily Drinker
4.763100E-03
Normal-vs-Weekly Drinker
1.105820E-02
Normal-vs-Occasional Drinker
2.125600E-01
Normal-vs-Social Drinker
2.505200E-01
Non Drinker-vs-Daily Drinker
6.070200E-01
Non Drinker-vs-Weekly Drinker
5.111200E-01
Non Drinker-vs-Occasional Drinker
1.952420E-01
Non Drinker-vs-Social Drinker
6.207800E-02
Daily Drinker-vs-Weekly Drinker
8.487000E-01
Daily Drinker-vs-Occasional Drinker
4.740800E-01
Daily Drinker-vs-Social Drinker
1.886390E-01
Weekly Drinker-vs-Occasional Drinker
6.417600E-01
Weekly Drinker-vs-Social Drinker
2.887400E-01
Occasional Drinker-vs-Social Drinker
4.015600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.079800E-02
Normal-vs-Grade 2
1.239780E-03
Normal-vs-Grade 3
1.502830E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.474000E-01
Grade 1-vs-Grade 3
9.706200E-01
Grade 1-vs-Grade 4
3.079800E-02
Grade 2-vs-Grade 3
8.661400E-01
Grade 2-vs-Grade 4
1.239780E-03
Grade 3-vs-Grade 4
1.502830E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.382180E-03
Normal-vs-NonDiabetic
1.953190E-01
Diabetic-vs-NonDiabetic
7.192600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.273600E-01
Normal-vs-NoPancreatitis
1.888600E-01
Pancreatitis-vs-NoPancreatitis
3.848400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.540280E-03
Normal-vs-N1
2.007600E-01
N0-vs-N1
7.890400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.552600E-01
Normal-vs-TP53-NonMutant
2.961600E-01
TP53-Mutant-vs-TP53-NonMutant
2.993400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
